English

BIO ESSENCE CORP.

EDGAR

BIOE Current report (8-K) · filed 2026-10-23

Annual consolidated revenue for 2025: about USD 1.898M, using the latest reported figures. The previous period, 2024, was about USD 323.9K.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

795 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 794711 USD Source

Operating margin

35.14%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 279290 USD Source
Revenue: 794711 USD Source

Operating cash flow

59.7 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -352320 USD Source
Operating Cash Flow: -411970 USD Source

Cash and cash equivalents: 28.7 thousand USD 2025-09-30 Source
Exact value

28741 USD
Long-term debt including current maturities: 56.8 thousand USD 2026-06-30 Source
Exact value

56836 USD
Shares outstanding: 53.8 million shares 2026-06-30 Source
Exact value

53809000 shares

Reported share-count change

41.57% · 15.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

38009000 shares · 2025-06-30· Source
53809000 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.91 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 136800 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 1897566 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 418112 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 500537 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 794711 USD · 2026-04-01 – 2026-06-30 Source

Net income

1.52 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: 12998 USD · 2025-07-01 – 2025-09-30 Source
Net income: 896197 USD · 2025-01-01 – 2025-12-31 Source
Net income: -132890 USD · 2025-01-01 – 2025-09-30 Source
Net income: 205373 USD · 2026-01-01 – 2026-03-31 Source
Net income: 270077 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

1.08 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: 328701 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 141728 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 1569753 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: 328701 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -411970 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -352320 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -411970 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-23.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2025-12-31
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 6 of 11 periods available· newest 2025-12-31
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
Capital expenditure: 4 of 11 periods available· newest 2023-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2024-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2025-12-31
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+485.8%

Prior period

USD 323,940

2024-01-01 – 2024-12-31
Current period

USD 1.9 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1897566 − 323940 = 1573626 USD

323940 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1897566 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIO ESSENCE CORP. · 2025-12-31 BIO ESSENCE CORP. (edgar:1723059) Year-over-year change in Revenue: 1573626 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1897566 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#355555 Filing: 000121390026035467 Input fundies:Revenue: 323940 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#355989 Filing: 000121390026035467
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.2 million

Prior period

−USD 1.31 million

2024-01-01 – 2024-12-31
Current period

USD 896,197

2025-01-01 – 2025-12-31

Exact inputs and evidence

896197 − -1308796 = 2204993 USD

-1308796 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
896197 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIO ESSENCE CORP. · 2025-12-31 BIO ESSENCE CORP. (edgar:1723059) Year-over-year change in Net income: 2204993 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 896197 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#422357 Filing: 000121390026035467 Input fundies:NetIncome: -1308796 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#422841 Filing: 000121390026035467
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+151.6%

Prior period

USD 623,865

2024-01-01 – 2024-12-31
Current period

USD 1.57 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1569753 − 623865 = 945888 USD

623865 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1569753 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIO ESSENCE CORP. · 2025-12-31 BIO ESSENCE CORP. (edgar:1723059) Year-over-year change in Operating cash flow: 945888 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 1569753 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#444001 Filing: 000121390026035467 Input fundies:OperatingCashFlow: 623865 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#444469 Filing: 000121390026035467
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 1.9 million 100% of revenue
Cost of revenue USD 469,153 25% of revenue
Operating expenses USD 528,402 28% of revenue
Operating income USD 900,011 47% of revenue
Tax, interest and other Derived USD 3,814 0.2% of revenue
Net income USD 896,197 47% of revenue

Cash

Operating cash flow USD 1.57 million 83% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 187% of revenue.
2021 Operating loss: operating costs were 197% of revenue.
2022 Operating loss: operating costs were 182% of revenue.
2023 Operating loss: operating costs were 163% of revenue.
2024 Operating loss: operating costs were 242% of revenue.
2025 47%53%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	958700	1791266 Derived	-832566	-236728 Derived	-595838	-740109 Derived	Source 2020-01-01 – 2020-12-31: 958700 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -832566 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -595838 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -732744 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 7365 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	887984	1745511 Derived	-857527	-209963 Derived	-647564	-1413614 Derived	Source 2021-01-01 – 2021-12-31: 887984 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -857527 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -647564 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -1294118 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 119496 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	621590	1132728 Derived	-511138	298541 Derived	-809679	-706983 Derived	Source 2022-01-01 – 2022-12-31: 621590 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -511138 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -809679 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -703241 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 3742 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	551506	897096 Derived	-345590	626289 Derived	-971879	-1029287 Derived	Source 2023-01-01 – 2023-12-31: 551506 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -345590 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -971879 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -1025673 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 3614 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	323940	783378 Derived	-459438	849358 Derived	-1308796	Unavailable	Source 2024-01-01 – 2024-12-31: 323940 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -459438 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -1308796 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 623865 USD Inspect Operating Cash Flow Open source
2025 2025-01-01 – 2025-12-31	1897566	997555 Derived	900011	3814 Derived	896197	Unavailable	Source 2025-01-01 – 2025-12-31: 1897566 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 900011 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 896197 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 1569753 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.9M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	958700	Revenue: 958700 Open source
20212021-12-31	Revenue	887984	Revenue: 887984 Open source
20222022-12-31	Revenue	621590	Revenue: 621590 Open source
20232023-12-31	Revenue	551506	Revenue: 551506 Open source
20242024-12-31	Revenue	323940	Revenue: 323940 Open source
20252025-12-31	Revenue	1897566	Revenue: 1897566 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

485.8% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 958700 Open source
20212021-12-31	Year over year	-7.4%	Revenue: 887984 Open source Revenue: 958700 Open source
20222022-12-31	Year over year	-30%	Revenue: 621590 Open source Revenue: 887984 Open source
20232023-12-31	Year over year	-11.3%	Revenue: 551506 Open source Revenue: 621590 Open source
20242024-12-31	Year over year	-41.3%	Revenue: 323940 Open source Revenue: 551506 Open source
20252025-12-31	Year over year	485.8%	Revenue: 1897566 Open source Revenue: 323940 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 47.4% 2025

Net margin 47.2% 2025

Free cash flow margin -186.6% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-86.8%	Operating Income: -832566 Open source Revenue: 958700 Open source
20212021-12-31	Operating margin	-96.6%	Operating Income: -857527 Open source Revenue: 887984 Open source
20222022-12-31	Operating margin	-82.2%	Operating Income: -511138 Open source Revenue: 621590 Open source
20232023-12-31	Operating margin	-62.7%	Operating Income: -345590 Open source Revenue: 551506 Open source
20242024-12-31	Operating margin	-141.8%	Operating Income: -459438 Open source Revenue: 323940 Open source
20252025-12-31	Operating margin	47.4%	Operating Income: 900011 Open source Revenue: 1897566 Open source
20202020-12-31	Net margin	-62.2%	Net Income: -595838 Open source Revenue: 958700 Open source
20212021-12-31	Net margin	-72.9%	Net Income: -647564 Open source Revenue: 887984 Open source
20222022-12-31	Net margin	-130.3%	Net Income: -809679 Open source Revenue: 621590 Open source
20232023-12-31	Net margin	-176.2%	Net Income: -971879 Open source Revenue: 551506 Open source
20242024-12-31	Net margin	-404%	Net Income: -1308796 Open source Revenue: 323940 Open source
20252025-12-31	Net margin	47.2%	Net Income: 896197 Open source Revenue: 1897566 Open source
20202020-12-31	Free cash flow margin	-77.2%	Revenue: 958700 Open source Operating Cash Flow: -732744 Open source Capital Expenditure: 7365 Open source
20212021-12-31	Free cash flow margin	-159.2%	Revenue: 887984 Open source Operating Cash Flow: -1294118 Open source Capital Expenditure: 119496 Open source
20222022-12-31	Free cash flow margin	-113.7%	Revenue: 621590 Open source Operating Cash Flow: -703241 Open source Capital Expenditure: 3742 Open source
20232023-12-31	Free cash flow margin	-186.6%	Revenue: 551506 Open source Operating Cash Flow: -1025673 Open source Capital Expenditure: 3614 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 323940 Open source Operating Cash Flow: 623865 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 1897566 Open source Operating Cash Flow: 1569753 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.6M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-732744	Operating Cash Flow: -732744 Open source
20212021-12-31	Operating cash flow	-1294118	Operating Cash Flow: -1294118 Open source
20222022-12-31	Operating cash flow	-703241	Operating Cash Flow: -703241 Open source
20232023-12-31	Operating cash flow	-1025673	Operating Cash Flow: -1025673 Open source
20242024-12-31	Operating cash flow	623865	Operating Cash Flow: 623865 Open source
20252025-12-31	Operating cash flow	1569753	Operating Cash Flow: 1569753 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-740109	Operating Cash Flow: -732744 Open source Capital Expenditure: 7365 Open source
20212021-12-31	Free cash flow	-1413614	Operating Cash Flow: -1294118 Open source Capital Expenditure: 119496 Open source
20222022-12-31	Free cash flow	-706983	Operating Cash Flow: -703241 Open source Capital Expenditure: 3742 Open source
20232023-12-31	Free cash flow	-1029287	Operating Cash Flow: -1025673 Open source Capital Expenditure: 3614 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: 623865 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: 1569753 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

590.7% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	196.5%	Total Liabilities: 3626659 Open source Total Assets: 1845487 Open source
20212021-12-31	Liabilities / assets	242.9%	Total Liabilities: 4127957 Open source Total Assets: 1699221 Open source
20222022-12-31	Liabilities / assets	309.2%	Total Liabilities: 4786140 Open source Total Assets: 1547725 Open source
20232023-12-31	Liabilities / assets	160.2%	Total Liabilities: 4418874 Open source Total Assets: 2758580 Open source
20242024-12-31	Liabilities / assets	1,156.5%	Total Liabilities: 3250114 Open source Total Assets: 281024 Open source
20252025-12-31	Liabilities / assets	590.7%	Total Liabilities: 2495367 Open source Total Assets: 422474 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.17× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	0.17×	Current Assets: 329625 Open source Current Liabilities: 1894891 Open source
20212021-12-31	Current assets / current liabilities	0.1×	Current Assets: 261962 Open source Current Liabilities: 2755964 Open source
20222022-12-31	Current assets / current liabilities	0.06×	Current Assets: 203831 Open source Current Liabilities: 3557830 Open source
20232023-12-31	Current assets / current liabilities	0.12×	Current Assets: 300000 Open source Current Liabilities: 2450456 Open source
20242024-12-31	Current assets / current liabilities	0.1×	Current Assets: 280692 Open source Current Liabilities: 2802700 Open source
20252025-12-31	Current assets / current liabilities	0.17×	Current Assets: 422377 Open source Current Liabilities: 2439211 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 595,838 Exact value Exact value: -595838 USD 2020-01-01 – 2020-12-31: -595838 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO ESSENCE CORP. · 2020-12-31 BIO ESSENCE CORP. (edgar:1723059) Net Income: -595838 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -595838 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390022016613/f10k2021_bioessence.htm#445674 Filing: 000121390022016613 The citation records this snapshot. The page link may show a newer release later.	−USD 732,744 Exact value Exact value: -732744 USD 2020-01-01 – 2020-12-31: -732744 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO ESSENCE CORP. · 2020-12-31 BIO ESSENCE CORP. (edgar:1723059) Operating Cash Flow: -732744 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -732744 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390022016613/f10k2021_bioessence.htm#471229 Filing: 000121390022016613 The citation records this snapshot. The page link may show a newer release later.	USD 7,365 Exact value Exact value: 7365 USD 2020-01-01 – 2020-12-31: 7365 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO ESSENCE CORP. · 2020-12-31 BIO ESSENCE CORP. (edgar:1723059) Capital Expenditure: 7365 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7365 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390022016613/f10k2021_bioessence.htm#475994 Filing: 000121390022016613 The citation records this snapshot. The page link may show a newer release later.	−USD 740,109 Calculation and evidence -732744 − 7365 USD Exact free cash flow: -740109 USD 2020-01-01 – 2020-12-31: -732744 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 7365 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO ESSENCE CORP. · 2020-12-31 BIO ESSENCE CORP. (edgar:1723059) Free cash flow: -740109 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -732744 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390022016613/f10k2021_bioessence.htm#471229 Filing: 000121390022016613 Input fundies:CapitalExpenditure: 7365 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390022016613/f10k2021_bioessence.htm#475994 Filing: 000121390022016613 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 647,564 Exact value Exact value: -647564 USD 2021-01-01 – 2021-12-31: -647564 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO ESSENCE CORP. · 2021-12-31 BIO ESSENCE CORP. (edgar:1723059) Net Income: -647564 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -647564 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390023024571/f10k2022_bioessence.htm#473538 Filing: 000121390023024571 The citation records this snapshot. The page link may show a newer release later.	−USD 1.29 million Exact value Exact value: -1294118 USD 2021-01-01 – 2021-12-31: -1294118 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO ESSENCE CORP. · 2021-12-31 BIO ESSENCE CORP. (edgar:1723059) Operating Cash Flow: -1294118 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1294118 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390023024571/f10k2022_bioessence.htm#413938 Filing: 000121390023024571 The citation records this snapshot. The page link may show a newer release later.	USD 119,496 Exact value Exact value: 119496 USD 2021-01-01 – 2021-12-31: 119496 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO ESSENCE CORP. · 2021-12-31 BIO ESSENCE CORP. (edgar:1723059) Capital Expenditure: 119496 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 119496 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390022016613/f10k2021_bioessence.htm#475306 Filing: 000121390022016613 The citation records this snapshot. The page link may show a newer release later.	−USD 1.41 million Calculation and evidence -1294118 − 119496 USD Exact free cash flow: -1413614 USD 2021-01-01 – 2021-12-31: -1294118 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 119496 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO ESSENCE CORP. · 2021-12-31 BIO ESSENCE CORP. (edgar:1723059) Free cash flow: -1413614 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1294118 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390023024571/f10k2022_bioessence.htm#413938 Filing: 000121390023024571 Input fundies:CapitalExpenditure: 119496 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390022016613/f10k2021_bioessence.htm#475306 Filing: 000121390022016613 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 809,679 Exact value Exact value: -809679 USD 2022-01-01 – 2022-12-31: -809679 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO ESSENCE CORP. · 2022-12-31 BIO ESSENCE CORP. (edgar:1723059) Net Income: -809679 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -809679 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390024032898/ea0203811-10k_bioessence.htm#332253 Filing: 000121390024032898 The citation records this snapshot. The page link may show a newer release later.	−USD 703,241 Exact value Exact value: -703241 USD 2022-01-01 – 2022-12-31: -703241 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO ESSENCE CORP. · 2022-12-31 BIO ESSENCE CORP. (edgar:1723059) Operating Cash Flow: -703241 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -703241 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390024032898/ea0203811-10k_bioessence.htm#364831 Filing: 000121390024032898 The citation records this snapshot. The page link may show a newer release later.	USD 3,742 Exact value Exact value: 3742 USD 2022-01-01 – 2022-12-31: 3742 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO ESSENCE CORP. · 2022-12-31 BIO ESSENCE CORP. (edgar:1723059) Capital Expenditure: 3742 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3742 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390024032898/ea0203811-10k_bioessence.htm#367428 Filing: 000121390024032898 The citation records this snapshot. The page link may show a newer release later.	−USD 706,983 Calculation and evidence -703241 − 3742 USD Exact free cash flow: -706983 USD 2022-01-01 – 2022-12-31: -703241 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 3742 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO ESSENCE CORP. · 2022-12-31 BIO ESSENCE CORP. (edgar:1723059) Free cash flow: -706983 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -703241 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390024032898/ea0203811-10k_bioessence.htm#364831 Filing: 000121390024032898 Input fundies:CapitalExpenditure: 3742 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390024032898/ea0203811-10k_bioessence.htm#367428 Filing: 000121390024032898 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 971,879 Exact value Exact value: -971879 USD 2023-01-01 – 2023-12-31: -971879 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO ESSENCE CORP. · 2023-12-31 BIO ESSENCE CORP. (edgar:1723059) Net Income: -971879 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -971879 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000101376225003850/ea0235539-10k_bioessence.htm#430389 Filing: 000101376225003850 The citation records this snapshot. The page link may show a newer release later.	−USD 1.03 million Exact value Exact value: -1025673 USD 2023-01-01 – 2023-12-31: -1025673 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO ESSENCE CORP. · 2023-12-31 BIO ESSENCE CORP. (edgar:1723059) Operating Cash Flow: -1025673 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1025673 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000101376225003850/ea0235539-10k_bioessence.htm#392944 Filing: 000101376225003850 The citation records this snapshot. The page link may show a newer release later.	USD 3,614 Exact value Exact value: 3614 USD 2023-01-01 – 2023-12-31: 3614 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIO ESSENCE CORP. · 2023-12-31 BIO ESSENCE CORP. (edgar:1723059) Capital Expenditure: 3614 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3614 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000101376225003850/ea0235539-10k_bioessence.htm#394568 Filing: 000101376225003850 The citation records this snapshot. The page link may show a newer release later.	−USD 1.03 million Calculation and evidence -1025673 − 3614 USD Exact free cash flow: -1029287 USD 2023-01-01 – 2023-12-31: -1025673 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 3614 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIO ESSENCE CORP. · 2023-12-31 BIO ESSENCE CORP. (edgar:1723059) Free cash flow: -1029287 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1025673 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000101376225003850/ea0235539-10k_bioessence.htm#392944 Filing: 000101376225003850 Input fundies:CapitalExpenditure: 3614 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000101376225003850/ea0235539-10k_bioessence.htm#394568 Filing: 000101376225003850 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 1.31 million Exact value Exact value: -1308796 USD 2024-01-01 – 2024-12-31: -1308796 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO ESSENCE CORP. · 2024-12-31 BIO ESSENCE CORP. (edgar:1723059) Net Income: -1308796 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1308796 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#422841 Filing: 000121390026035467 The citation records this snapshot. The page link may show a newer release later.	USD 623,865 Exact value Exact value: 623865 USD 2024-01-01 – 2024-12-31: 623865 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO ESSENCE CORP. · 2024-12-31 BIO ESSENCE CORP. (edgar:1723059) Operating Cash Flow: 623865 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 623865 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#444469 Filing: 000121390026035467 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	USD 896,197 Exact value Exact value: 896197 USD 2025-01-01 – 2025-12-31: 896197 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIO ESSENCE CORP. · 2025-12-31 BIO ESSENCE CORP. (edgar:1723059) Net Income: 896197 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 896197 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#422357 Filing: 000121390026035467 The citation records this snapshot. The page link may show a newer release later.	USD 1.57 million Exact value Exact value: 1569753 USD 2025-01-01 – 2025-12-31: 1569753 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIO ESSENCE CORP. · 2025-12-31 BIO ESSENCE CORP. (edgar:1723059) Operating Cash Flow: 1569753 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:53:59Z Snapshot: 096716bae798add286d08cd489c7f851fb84a20751515c033315b12b820b0d23 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1723059/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1569753 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1723059/000121390026035467/ea0283075-10k_bioessence.htm#444001 Filing: 000121390026035467 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 1,616 latest values · 1,616 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001723059, 1723059, BIOE, N/A, edgar:1723059

Also known as BIO ESSENCE CORP, BIO ESSENCE CORP., Bio Essence Corp

BIO ESSENCE CORP.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation